Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:30 PM
Ignite Modification Date:
2025-12-24 @ 7:30 PM
NCT ID:
NCT07153003
Eligibility Criteria:
Inclusion Criteria:
* Primary TKA
* Primary THA
* Age \> 18 years
Exclusion Criteria:
* Age \< 18 years
* Revision or partial TKA/THA
* Pregnant or breast-feeding women
* Simultaneous bilateral TKA/THA
* Primary TKA/THA due to oncologic reason
* Anaphylaxis to opioids
* Renal or liver failure
* Prior opioid use disorder/ substance use disorder
* Opioid use within 3 months prior to surgery
* Patients needing a translator and those with dementia or other cognitive deficits
* Patients taking Monoamine Oxidase Inhibitor (MOAI) medications (phenelzine, tranylcypromine) or benzodiazepine medications (alprazolam, diazepam, lorazepam, etc)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07153003
Study Brief:
Protocol Section:
NCT07153003